HEIDY KING-JONES

Track

Insider profile

HEIDY KING-JONES's trades of Spyre Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-10-01
PlS Planned sale
43,155 -14.3%
321.81
US$1,295,564 		43,155 -14.3% 321.81 US$1,295,564
2026-10-02 2026-10-01
PlS Planned sale
46,051 +9.3%
19.59
US$4,394,407 		46,051 +9.3% 19.59 US$4,394,407
2026-10-02 2026-10-01
PlS Planned sale
60,531 -6.4%
235.14
US$2,184,429 		60,531 -6.4% 235.14 US$2,184,429
2026-10-02 2026-10-01
PlS Planned sale
16,605 -52.9%
90.35
US$1,500,262 		16,605 -52.9% 90.35 US$1,500,262
2026-10-02 2026-10-01
PlS Planned sale
400 -1.3%
89.24
US$35,696 		400 -1.3% 89.24 US$35,696
2026-10-01 2026-10-01
PrS Proposed sale
29,335
89.03
US$2,611,695 		29,335 89.03 US$2,611,695
2026-09-03 2026-09-02
PlS Planned sale
400 -12.3%
90.00
US$36,000 		400 -12.3% 90.00 US$36,000
2026-09-03 2026-09-01
PlS Planned sale
400 -12.3%
89.38
US$35,752 		400 -12.3% 89.38 US$35,752
2026-09-03 2026-09-01
PlS Planned sale
6,206 -65.7%
88.17
US$547,183 		6,206 -65.7% 88.17 US$547,183
2026-09-03 2026-09-01
PlS Planned sale
16,548 -63.6%
87.20
US$1,442,986 		16,548 -63.6% 87.20 US$1,442,986
2026-09-03 2026-09-01
PlS Planned sale
4,845 -15.7%
86.40
US$418,608 		4,845 -15.7% 86.40 US$418,608
2026-09-01 2026-09-01
PrS Proposed sale
46,665
89.33
US$4,168,584 		46,665 89.33 US$4,168,584